Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 175

1.

Primary cervical screening with high risk human papillomavirus testing: observational study.

Rebolj M, Rimmer J, Denton K, Tidy J, Mathews C, Ellis K, Smith J, Evans C, Giles T, Frew V, Tyler X, Sargent A, Parker J, Holbrook M, Hunt K, Tidbury P, Levine T, Smith D, Patnick J, Stubbs R, Moss S, Kitchener H.

BMJ. 2019 Feb 6;364:l240. doi: 10.1136/bmj.l240.

2.

Blood pressure is a beautiful (but imperfect) biomarker of hypertension. The quixotic quest that fuels the hypertension guideline industry.

Giles TD, Kostis JB, Fernandez C.

J Clin Hypertens (Greenwich). 2018 May;20(5):840-841. doi: 10.1111/jch.13286. Epub 2018 May 9. No abstract available.

3.

Analysis of decreases in systemic arterial pressure and heart rate in response to the hydrogen sulfide donor sodium sulfide.

Swan KW, Song BM, Chen AL, Chen TJ, Chan RA, Guidry BT, Katakam PVG, Kerut EK, Giles TD, Kadowitz PJ.

Am J Physiol Heart Circ Physiol. 2017 Oct 1;313(4):H732-H743. doi: 10.1152/ajpheart.00729.2016. Epub 2017 Jun 30.

4.

Rationale for nebivolol/valsartan combination for hypertension: review of preclinical and clinical data.

Giles TD, Cockcroft JR, Pitt B, Jakate A, Wright HM.

J Hypertens. 2017 Sep;35(9):1758-1767. doi: 10.1097/HJH.0000000000001412. Review.

5.

Apolipoproteins and Blood Pressure: A Story of Evolution in Biomarker Analysis.

Fernandez C, Romero A, Giles TD.

J Am Coll Cardiol. 2017 Mar 28;69(12):1575-1576. doi: 10.1016/j.jacc.2017.02.005. No abstract available.

6.

Efficacy of nebivolol-valsartan single-pill combination in obese and nonobese patients with hypertension.

Mende CW, Giles TD, Bharucha DB, Ferguson WG, Mallick M, Patel MD.

J Clin Hypertens (Greenwich). 2017 Jun;19(6):632-639. doi: 10.1111/jch.12965. Epub 2017 Jan 11.

7.

Methodological evaluation of the noninvasive estimation of central systolic blood pressure in nontreated patients: the Bogalusa Heart Study.

Fernandez C, Hsu R, Sander G, Hussain A, Barshop R, Li S, Shu T, Zhang T, Galazka P, Chen W, Bazzano L, Giles TD.

Blood Press Monit. 2017 Apr;22(2):95-100. doi: 10.1097/MBP.0000000000000224.

PMID:
27902495
8.

A mathematical algorithm for quantification of CT image noise.

Kerut EK, To F, Turner M, McKinnie J, Giles T.

Echocardiography. 2017 Jan;34(1):116-118. doi: 10.1111/echo.13389. Epub 2016 Sep 28.

PMID:
27677900
9.

Nebivolol has a beneficial effect in monocrotaline-induced pulmonary hypertension.

Pankey EA, Edward JA, Swan KW, Bourgeois CR, Bartow MJ, Yoo D, Peak TA, Song BM, Chan RA, Murthy SN, Prieto MC, Giles TD, Kadowitz PJ.

Can J Physiol Pharmacol. 2016 Jul;94(7):758-68. doi: 10.1139/cjpp-2015-0431. Epub 2016 Feb 1.

PMID:
27172427
10.

Fixed-dose combination therapy of nebivolol and valsartan for the treatment of hypertension.

Sander GE, Fernandez C, Giles TD.

Expert Rev Cardiovasc Ther. 2016;14(5):563-72. doi: 10.1586/14779072.2016.1167598. Epub 2016 Apr 7. Review.

PMID:
26986445
11.

Prehypertension: Defining the Transitional Phenotype.

Fernandez C, Sander GE, Giles TD.

Curr Hypertens Rep. 2016 Jan;18(1):2. doi: 10.1007/s11906-015-0611-8. Review.

PMID:
26694821
12.

Correlations of plasma renin activity and aldosterone concentration with ambulatory blood pressure responses to nebivolol and valsartan, alone and in combination, in hypertension.

Giles TD, Bakris G, Oparil S, Weber MA, Li H, Mallick M, Bharucha DB, Chen C, Ferguson WG; NAC-MD-01 Substudy Investigators.

J Am Soc Hypertens. 2015 Nov;9(11):845-54. doi: 10.1016/j.jash.2015.08.003. Epub 2015 Aug 12.

13.

Endothelial Progenitor Cells as a Biomarker for Transitional Phenotypes in Hypertension.

Giles TD, Sander GE.

J Clin Hypertens (Greenwich). 2015 Aug;17(8):580-1. doi: 10.1111/jch.12567. Epub 2015 May 7. No abstract available.

14.

Apathy towards ambulatory blood pressure monitoring use in hypertension: is it due to cognitive dissonance, money, or both?

Giles TD.

Hypertension. 2015 Jun;65(6):1156-7. doi: 10.1161/HYPERTENSIONAHA.115.05113. Epub 2015 Apr 13. No abstract available.

PMID:
25870191
15.

The 'W' prawn-trawl with emphasised drag-force transfer to its centre line to reduce overall system drag.

Balash C, Sterling D, Binns J, Thomas G, Bose N.

PLoS One. 2015 Mar 9;10(3):e0119622. doi: 10.1371/journal.pone.0119622. eCollection 2015.

16.

Nebivolol and valsartan as a fixed-dose combination for the treatment of hypertension.

Sander GE, Giles TD.

Expert Opin Pharmacother. 2015 Apr;16(5):763-70. doi: 10.1517/14656566.2015.1020790. Review.

PMID:
25747524
17.

Digital plethysmography and arginine metabolism in prehypertension: effect of nebivolol therapy.

Kandavar R, Fernandez C, Sander GE, Kim C, Velaga S, Sukhanov S, Delafontaine P, Egan P, Roffidal LE, Giles TD.

J Clin Hypertens (Greenwich). 2015 Jan;17(1):14-9. doi: 10.1111/jch.12451. Epub 2014 Dec 15.

18.

Long-term safety of nebivolol and valsartan combination therapy in patients with hypertension: an open-label, single-arm, multicenter study.

Neutel JM, Giles TD, Punzi H, Weiss RJ, Li H, Finck A.

J Am Soc Hypertens. 2014 Dec;8(12):915-20. doi: 10.1016/j.jash.2014.09.017. Epub 2014 Sep 28.

PMID:
25492835
19.

ASH hypertension self-assessment program.

Giles TD.

J Am Soc Hypertens. 2014 Jul;8(7):517-8. No abstract available.

PMID:
25207339
20.

Vascular stiffness is a biomarker of global cardiovascular risk.

Sander GE, Giles TD.

J Clin Hypertens (Greenwich). 2014 Sep;16(9):625-6. doi: 10.1111/jch.12380. Epub 2014 Jul 31. No abstract available.

21.

Guidelines for the management of thyroid cancer.

Perros P, Boelaert K, Colley S, Evans C, Evans RM, Gerrard Ba G, Gilbert J, Harrison B, Johnson SJ, Giles TE, Moss L, Lewington V, Newbold K, Taylor J, Thakker RV, Watkinson J, Williams GR; British Thyroid Association.

Clin Endocrinol (Oxf). 2014 Jul;81 Suppl 1:1-122. doi: 10.1111/cen.12515. No abstract available.

PMID:
24989897
22.

Efficacy and safety of nebivolol and valsartan as fixed-dose combination in hypertension: a randomised, multicentre study.

Giles TD, Weber MA, Basile J, Gradman AH, Bharucha DB, Chen W, Pattathil M; NAC-MD-01 Study Investigators.

Lancet. 2014 May 31;383(9932):1889-98. doi: 10.1016/S0140-6736(14)60614-0. Erratum in: Lancet. 2016 Sep 24;388(10051):1280.

PMID:
24881993
23.

Molecular characterization of adipose tissue in the African elephant (Loxodonta africana).

Nilsson EM, Fainberg HP, Choong SS, Giles TC, Sells J, May S, Stansfield FJ, Allen WR, Emes RD, Mostyn A, Mongan NP, Yon L.

PLoS One. 2014 Mar 14;9(3):e91717. doi: 10.1371/journal.pone.0091717. eCollection 2014.

24.

Hypertension 101: the place to start.

Giles TD.

J Clin Hypertens (Greenwich). 2014 Jan;16(1):4-5. doi: 10.1111/jch.12239. Epub 2013 Dec 17. No abstract available.

25.

Incidence of atrial fibrillation in a population with impaired glucose tolerance: the contribution of glucose metabolism and other risk factors. A post hoc analysis of the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

Latini R, Staszewsky L, Sun JL, Bethel MA, Disertori M, Haffner SM, Holman RR, Chang F, Giles TD, Maggioni AP, Rutten GE, Standl E, Thomas L, Tognoni G, Califf RM, McMurray JJ.

Am Heart J. 2013 Nov;166(5):935-40.e1. doi: 10.1016/j.ahj.2013.08.012. Epub 2013 Oct 7.

PMID:
24176451
26.

Inter-arm difference in systolic blood pressure-"the plot stiffens"-.

Giles TD.

J Clin Hypertens (Greenwich). 2013 Dec;15(12):878-9. doi: 10.1111/jch.12193. Epub 2013 Sep 30. No abstract available.

27.

Nebivolol monotherapy in younger adults (younger than 55 years) with hypertension: a randomized, placebo-controlled trial.

Giles TD, Khan BV, Lato J, Brener L, Ma Y, Lukic T.

J Clin Hypertens (Greenwich). 2013 Sep;15(9):687-93. doi: 10.1111/jch.12169. Epub 2013 Jul 16.

28.

Hypertension and dementia--the elephant in the room.

Giles T.

J Clin Hypertens (Greenwich). 2013 Sep;15(9):611. doi: 10.1111/jch.12148. Epub 2013 Jun 17. No abstract available.

29.

Predictors of stroke in patients with impaired glucose tolerance: results from the Nateglinide and Valsartan in Impaired Glucose Tolerance Outcomes Research trial.

Preiss D, Giles TD, Thomas LE, Sun JL, Haffner SM, Holman RR, Standl E, Mazzone T, Rutten GE, Tognoni G, Chiang FT, McMurray JJ, Califf RM.

Stroke. 2013 Sep;44(9):2590-3. doi: 10.1161/STROKEAHA.113.001177. Epub 2013 Jul 30.

PMID:
23899915
30.

Women have significantly greater difference between central and peripheral arterial pressure compared with men: the Bogalusa Heart Study.

Chester R, Sander G, Fernandez C, Chen W, Berenson G, Giles T.

J Am Soc Hypertens. 2013 Sep-Oct;7(5):379-85. doi: 10.1016/j.jash.2013.05.007. Epub 2013 Jul 12.

31.

Rationale for establishing a mechanism to increase reimbursement to hypertension specialists.

Elliott WJ, Egan B, Giles TD, Bakris GL, White WB, Sansone TM.

J Clin Hypertens (Greenwich). 2013 Jun;15(6):397-403. doi: 10.1111/jch.12090. Epub 2013 Apr 11.

32.

Diastolic blood pressure and hypertension phenotypes: the US Food and Drug Administration has it right.

Giles TD, Sander GE.

J Clin Hypertens (Greenwich). 2013 Mar;15(3):145-6. doi: 10.1111/jch.12053. Epub 2012 Dec 26. No abstract available.

33.

Predictors of incident heart failure hospitalizations among patients with impaired glucose tolerance: insight from the Nateglinide And Valsartan in Impaired Glucose Tolerance Outcomes Research study.

Wong YW, Thomas L, Sun JL, McMurray JJ, Krum H, Hernandez AF, Rutten GE, Leiter LA, Standl E, Haffner SM, Mazzone T, Martinez FA, Tognoni G, Giles T, Califf RM.

Circ Heart Fail. 2013 Mar;6(2):203-10. doi: 10.1161/CIRCHEARTFAILURE.112.000086. Epub 2013 Feb 6.

PMID:
23388113
34.

Biomarkers, cardiovascular disease, and hypertension.

Giles T.

J Clin Hypertens (Greenwich). 2013 Jan;15(1):1. doi: 10.1111/jch.12014. Epub 2012 Sep 28. No abstract available.

35.

Ambulatory blood pressure monitoring should be included in the National Health and Nutritional Examination Survey (NHANES).

Giles TD, Black HR, Messerli F, White WB.

J Am Soc Hypertens. 2012 Sep-Oct;6(5):364-6. doi: 10.1016/j.jash.2012.07.002. Epub 2012 Aug 28. No abstract available.

PMID:
22951099
36.

Inter-arm difference in blood pressure may have serious research and clinical implications.

Giles TD, Egan P.

J Clin Hypertens (Greenwich). 2012 Aug;14(8):491-2. doi: 10.1111/j.1751-7176.2012.00668.x. Epub 2012 Jun 7. No abstract available.

37.

Comparative efficacy of aliskiren/valsartan vs valsartan in nocturnal dipper and nondipper hypertensive patients: a pooled analysis.

Giles TD, Alessi T, Purkayastha D, Zappe D.

J Clin Hypertens (Greenwich). 2012 May;14(5):299-306. doi: 10.1111/j.1751-7176.2012.00608.x. Epub 2012 Mar 16.

38.

Impaired vasodilation in the pathogenesis of hypertension: focus on nitric oxide, endothelial-derived hyperpolarizing factors, and prostaglandins.

Giles TD, Sander GE, Nossaman BD, Kadowitz PJ.

J Clin Hypertens (Greenwich). 2012 Apr;14(4):198-205. doi: 10.1111/j.1751-7176.2012.00606.x. Review.

39.

The new International Classification of Diseases (ICD-10): the hypertension community needs a greater input.

Giles TD, Sander GE.

J Clin Hypertens (Greenwich). 2012 Jan;14(1):1-2. doi: 10.1111/j.1751-7176.2011.00546.x. No abstract available.

40.

The genetics of hypertension--where to look?

Giles TD.

J Clin Hypertens (Greenwich). 2011 Dec;13(12):870. doi: 10.1111/j.1751-7176.2011.00533.x. Epub 2011 Sep 26. No abstract available.

41.

Performance evaluation of the DNA methylation biomarker SHOX2 for the aid in diagnosis of lung cancer based on the analysis of bronchial aspirates.

Dietrich D, Kneip C, Raji O, Liloglou T, Seegebarth A, Schlegel T, Flemming N, Rausch S, Distler J, Fleischhacker M, Schmidt B, Giles T, Walshaw M, Warburton C, Liebenberg V, Field JK.

Int J Oncol. 2012 Mar;40(3):825-32. doi: 10.3892/ijo.2011.1264. Epub 2011 Nov 16.

PMID:
22108652
42.

What is the blood pressure goal for the elder patient 75 years of age or older?

Sander GE, Giles TD.

Curr Cardiol Rep. 2011 Dec;13(6):485-91. doi: 10.1007/s11886-011-0222-1.

PMID:
21971761
43.

Resistant hypertension: concepts and approach to management.

Sander GE, Giles TD.

Curr Hypertens Rep. 2011 Oct;13(5):347-55. doi: 10.1007/s11906-011-0226-7. Review.

PMID:
21922182
44.

Potassium: a non-celebrity cation.

Roffidal-Blanco C, Giles TD.

J Clin Hypertens (Greenwich). 2011 Aug;13(8):541-2. doi: 10.1111/j.1751-7176.2011.00494.x. Epub 2011 Jul 14. No abstract available.

45.

It is all about flow or, why there will never be one optimal blood pressure goal for every patient with hypertension.

Giles TD.

J Clin Hypertens (Greenwich). 2011 Jun;13(6):395-6. doi: 10.1111/j.1751-7176.2011.00436.x. Epub 2011 Mar 21. No abstract available.

46.

The interobserver reproducibility of thyroid fine-needle aspiration using the UK Royal College of Pathologists' classification system.

Kocjan G, Chandra A, Cross PA, Giles T, Johnson SJ, Stephenson TJ, Roughton M, Poller DN.

Am J Clin Pathol. 2011 Jun;135(6):852-9. doi: 10.1309/AJCPZ33MVMGZKEWU.

PMID:
21571958
47.

Progression of pre-hypertension.

Giles TD.

Curr Hypertens Rep. 2011 Aug;13(4):262-4. doi: 10.1007/s11906-011-0208-9. No abstract available.

PMID:
21556701
48.

Stimulus response of blood pressure in black and white young individuals helps explain racial divergence in adult cardiovascular disease: the Bogalusa Heart Study.

Berenson GS, Chen W, Dasmahapatra P, Fernandez C, Giles T, Xu J, Srinivasan SR.

J Am Soc Hypertens. 2011 Jul-Aug;5(4):230-8. doi: 10.1016/j.jash.2011.02.006. Epub 2011 Apr 13.

49.

Moderate versus intensive treatment of hypertension using amlodipine/valsartan and with the addition of hydrochlorothiazide for patients uncontrolled on angiotensin receptor blocker monotherapy: results in racial/ethnic subgroups.

Ofili EO, Oparil S, Giles T, Pitt B, Purkayastha D, Hilkert R, Samuel R, Sowers JR.

J Am Soc Hypertens. 2011 Jul-Aug;5(4):249-58. doi: 10.1016/j.jash.2011.02.007. Epub 2011 Apr 8.

50.

Thiazide diuretics and β-blockers in the treatment of hypertension in diabetes mellitus.

Sander GE, Giles TD.

J Clin Hypertens (Greenwich). 2011 Apr;13(4):296-300. doi: 10.1111/j.1751-7176.2011.00454.x. No abstract available.

Supplemental Content

Loading ...
Support Center